These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35324081)

  • 1. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
    Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
    J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
    Matthews LT; Atukunda EC; Owembabazi M; Kalyebera KP; Psaros C; Chitneni P; Hendrix CW; Marzinke MA; Anderson PL; Isehunwa OO; Hurwitz KE; Bennett K; Muyindike W; Bangsberg DR; Haberer JE; Marrazzo JM; Bwana MB
    PLoS Med; 2023 Feb; 20(2):e1004088. PubMed ID: 36795763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
    Koss CA; Charlebois ED; Ayieko J; Kwarisiima D; Kabami J; Balzer LB; Atukunda M; Mwangwa F; Peng J; Mwinike Y; Owaraganise A; Chamie G; Jain V; Sang N; Olilo W; Brown LB; Marquez C; Zhang K; Ruel TD; Camlin CS; Rooney JF; Black D; Clark TD; Gandhi M; Cohen CR; Bukusi EA; Petersen ML; Kamya MR; Havlir DV;
    Lancet HIV; 2020 Apr; 7(4):e249-e261. PubMed ID: 32087152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'I still desire to have a child': a qualitative analysis of intersectional HIV- and childlessness-related stigma in rural southwestern Uganda.
    Pratt MC; Owembabazi M; Muyindike W; Kaida A; Marrazzo JM; Bangsberg DR; Bwana MB; Psaros C; Turan J; Atukunda EC; Matthews LT
    Cult Health Sex; 2023 Feb; 25(2):143-158. PubMed ID: 35015604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond HIV-serodiscordance: Partnership communication dynamics that affect engagement in safer conception care.
    Matthews LT; Burns BF; Bajunirwe F; Kabakyenga J; Bwana M; Ng C; Kastner J; Kembabazi A; Sanyu N; Kusasira A; Haberer JE; Bangsberg DR; Kaida A
    PLoS One; 2017; 12(9):e0183131. PubMed ID: 28880892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
    Camlin CS; Koss CA; Getahun M; Owino L; Itiakorit H; Akatukwasa C; Maeri I; Bakanoma R; Onyango A; Atwine F; Ayieko J; Kabami J; Mwangwa F; Atukunda M; Owaraganise A; Kwarisiima D; Sang N; Bukusi EA; Kamya MR; Petersen ML; Cohen CR; Charlebois ED; Havlir DV
    AIDS Behav; 2020 Jul; 24(7):2149-2162. PubMed ID: 31955361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda.
    Mujugira A; Nakyanzi A; Kasiita V; Kamusiime B; Nalukwago GK; Nalumansi A; Twesigye CC; Muwonge TR; Baeten JM; Wyatt MA; Haberer JE; Ware NC
    J Int AIDS Soc; 2021 Sep; 24(9):e25782. PubMed ID: 34473405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.
    Matthews LT; Jaggernath M; Kriel Y; Smith PM; O'Neil K; Haberer JE; Hendrix C; Baeten JM; Ware NC; Wirth K; Psaros C; Bangsberg DR; Smit JA
    BMJ Open; 2019 Jul; 9(7):e027227. PubMed ID: 31350241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
    Muhumuza R; Ssemata AS; Kakande A; Ahmed N; Atujuna M; Nomvuyo M; Bekker LG; Dietrich JJ; Tshabalala G; Hornschuh S; Maluadzi M; Chibanda-Stranix L; Nematadzira T; Weiss HA; Nash S; Fox J; Seeley J
    Arch Sex Behav; 2021 May; 50(4):1729-1742. PubMed ID: 33954824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of Pre-exposure Prophylaxis (PrEP) for HIV prevention among men living with HIV in the context of reproductive goals in South Africa: a qualitative study.
    Ntinga X; Isehunwa OO; Msimango LI; Smith PM; Matthews LT; Van Heerden A
    BMC Public Health; 2024 Feb; 24(1):553. PubMed ID: 38389039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Client experiences with "Dynamic Choice Prevention," a model for flexible patient-centred HIV prevention delivery in rural Eastern Africa.
    Camlin CS; Arunga T; Johnson-Peretz J; Akatukwasa C; Atwine F; Onyango A; Owino L; Kamya MR; Petersen ML; Chamie G; Kakande E; Kabami J; Balzer LB; Havlir DV; Ayieko J
    J Int AIDS Soc; 2024 Jul; 27(7):e26336. PubMed ID: 39020454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa.
    Matthews LT; Jaggernath M; Kriel Y; Smith PM; Haberer JE; Baeten JM; Hendrix CW; Ware NC; Moodley P; Pillay M; Bennett K; Bassler J; Psaros C; Hurwitz KE; Bangsberg DR; Smit JA
    AIDS; 2024 Jul; 38(9):1342-1354. PubMed ID: 38752557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
    Nakamanya S; Kawuma R; Kibuuka D; Kusemererwa S; McCormack S; Ruzagira E; Seeley J;
    PLoS One; 2022; 17(7):e0271104. PubMed ID: 35905052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Buzibye A; Omali D; Chinyenze K; Kuteesa M; Kaleebu P; Price MA
    J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.